Manufacturers Life Insurance Company, The Gilead Sciences, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 6,308,718 shares of GILD stock, worth $657 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
6,308,718
Previous 6,342,411
0.53%
Holding current value
$657 Million
Previous $532 Million
9.62%
% of portfolio
0.54%
Previous 0.49%
Shares
34 transactions
Others Institutions Holding GILD
# of Institutions
2,072Shares Held
1.02BCall Options Held
9.63MPut Options Held
10.2M-
Black Rock Inc. New York, NY121MShares$12.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.46 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.28 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.03 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...